Search research articles
Contact Us
Filters
Showing results (221-230 of 259) with videos related to
Page
of 26
Sort By:
Journal of Primary Care & Community Health
|
June 9, 2022
Cancer Survivors, Oncology, and Primary Care Perspectives on Survivorship Care: An Integrative Review
Madeleine Love, Marc Debay, Anne Charity Hudley, et al.
Cancers
|
March 29, 2023
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma
Colton Ladbury, Savita Dandapani, Claire Hao, et al.
Translational Lung Cancer Research
|
June 15, 2026
Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma
Amanda Reyes, Isa Mambetsariev, Jeremy Fricke, et al.
Annals of Surgical Oncology
|
November 8, 2013
Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer
Arya Amini, Jaffer Ajani, Ritsuko Komaki, et al.
Cancers
|
November 27, 2025
Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review
Douglas Dias E Silva, Beatriz Viesser Miyamura, Isa Mambetsariev, et al.
Cancers
|
October 14, 2022
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Clinical Lung Cancer
|
May 25, 2022
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
Steven E Schild, Xiaofei Wang, Christine M Bestvina, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 5, 2023
Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617
Colton Ladbury, Richard Li, Anseh Danesharasteh, et al.
Eclinicalmedicine
|
October 7, 2025
Osimertinib plus consolidative radiotherapy for advanced <i>EGFR</i> mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trial
Sagus Sampath, Sawsan Rashdan, Puneeth Iyengar, et al.
NPJ Precision Oncology
|
June 19, 2024
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 259) with videos related to
Sort By:
Page
of 26
Journal of Primary Care & Community Health
|
June 9, 2022
Cancer Survivors, Oncology, and Primary Care Perspectives on Survivorship Care: An Integrative Review
Madeleine Love, Marc Debay, Anne Charity Hudley, et al.
Cancers
|
March 29, 2023
Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma
Colton Ladbury, Savita Dandapani, Claire Hao, et al.
Translational Lung Cancer Research
|
June 15, 2026
Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma
Amanda Reyes, Isa Mambetsariev, Jeremy Fricke, et al.
Annals of Surgical Oncology
|
November 8, 2013
Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer
Arya Amini, Jaffer Ajani, Ritsuko Komaki, et al.
Cancers
|
November 27, 2025
Current Clinical Paradigm and Therapeutic Advancements in Thymic Malignancies: A Narrative Review
Douglas Dias E Silva, Beatriz Viesser Miyamura, Isa Mambetsariev, et al.
Cancers
|
October 14, 2022
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Clinical Lung Cancer
|
May 25, 2022
Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer
Steven E Schild, Xiaofei Wang, Christine M Bestvina, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 5, 2023
Explainable Artificial Intelligence to Identify Dosimetric Predictors of Toxicity in Patients with Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of RTOG 0617
Colton Ladbury, Richard Li, Anseh Danesharasteh, et al.
Eclinicalmedicine
|
October 7, 2025
Osimertinib plus consolidative radiotherapy for advanced <i>EGFR</i> mutant non-small cell lung cancer: a multicentre, single-arm, phase 2 trial
Sagus Sampath, Sawsan Rashdan, Puneeth Iyengar, et al.
NPJ Precision Oncology
|
June 19, 2024
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Page
of 26